{
  "meta": {
    "data_length": 1,
    "message": "Document id doc:fda.datroway retrieved successfully",
    "request_url": "http://api.moalmanac.org/documents?document_id=doc%3Afda.datroway",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.00433,
    "timestamp_received": "2026-04-06T14:53:34.850523+00:00Z",
    "timestamp_returned": "2026-04-06T14:53:34.854853+00:00Z",
    "trace_id": "dc156003-121b-4953-806f-fdbd0c8bd38a"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://dev.moalmanac.org",
    "last_updated": "2026-03-05"
  },
  "data": [
    {
      "id": "doc:fda.datroway",
      "type": "Document",
      "documentType": "Regulatory approval",
      "name": "Datroway (datopotamab deruxtecan-dlnk) [package insert]. FDA.",
      "title": null,
      "aliases": [],
      "description": "Daiichi Sankyo, Inc. Datroway (datopotamab deruxtecan-dlnk) [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761464s000lbl.pdf. Revised June 2025. Accessed September 2, 2025.",
      "urls": [
        "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761464s000lbl.pdf",
        "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761464"
      ],
      "doi": null,
      "pmid": null,
      "extensions": [
        {
          "name": "agent",
          "value": {
            "id": "fda",
            "type": "Agent",
            "agentType": "organization",
            "name": "Food and Drug Administration",
            "description": "Regulatory agency that approves drugs for use in the United States.",
            "extensions": [
              {
                "name": "last_updated",
                "value": "2026-03-02",
                "description": ""
              },
              {
                "name": "url",
                "value": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm",
                "description": ""
              }
            ]
          },
          "description": "The organization that published this document."
        },
        {
          "name": "company",
          "value": "Daiichi Sankyo, Inc.",
          "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_brand",
          "value": "Datroway",
          "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "drug_name_generic",
          "value": "datopotamab deruxtecan-dlnk",
          "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
        },
        {
          "name": "first_publication_date",
          "value": "2025-06-23",
          "description": "The publication date for the initial version of this document."
        },
        {
          "name": "identification_number",
          "value": 761464,
          "description": "Identification number used by the publishing organization."
        },
        {
          "name": "publication_date",
          "value": "2025-06-23",
          "description": "The publication date for the document."
        },
        {
          "name": "status",
          "value": "Active",
          "description": "Whether this document is Active or Deprecated within moalmanac-db."
        }
      ]
    }
  ]
}